Related Experiment Video
Updated: Nov 8, 2025
10:16
Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets
Published on: March 12, 2019
45.7K
Histamine H2 receptor radioligands: triumphs and challenges
Steffen Pockes1,2,3, Katharina Tropmann1
1Institute of Pharmacy, University of Regensburg, Universitätsstraße 31, Regensburg, D-93053, Germany.
Future Medicinal Chemistry
|April 28, 2021
Summary
Radioligands are crucial for studying the histamine H2 receptor (H2R). New G protein-biased radioligands like [3H]UR-KAT479 advance understanding of H2R's central nervous system functions.
Area of Science:
- Pharmacology
- Neuroscience
- Radiochemistry
Background:
- Histamine H2 receptor (H2R) research heavily relies on radioligands to understand its function.
- Early studies used radiolabeling for receptor expression analysis in human and rodent tissues.
- Radioligands are vital pharmacological tools for in vitro assays.
Purpose of the Study:
- To highlight the evolution and significance of radioligands in H2R research.
- To introduce the novel G protein-biased radioligand [3H]UR-KAT479.
- To emphasize the potential of new radioligands in exploring the H2R's role in the central nervous system.
Main Methods:
- Review of radioligand development for H2R research.
- Discussion of radiolabeling techniques (tritium vs. carbon-14).
- Introduction of [3H]UR-KAT479 as a G protein-biased radioligand.
Main Results:
- Radioligands have been instrumental since the discovery of H2R.
- Tritium labeling is common for in vitro assays, while carbon-14 is preferred for metabolic studies.
- The development of [3H]UR-KAT479 marks a significant advancement.
Conclusions:
- Radioligands are essential tools for H2R investigation.
- Novel radioligands like [3H]UR-KAT479 offer new avenues for research.
- Further studies using advanced radioligands are needed to elucidate the H2R's central nervous system functions.
![Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F63025.jpg&w=3840&q=50)
Related Concept Videos
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
657
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
657
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
415
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
415
01:25Drug-Receptor Interaction: Agonist
3.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.3K
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
553
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
553
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
305
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
305
01:29The Two-State Receptor Model
2.7K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.7K